Rational molecular assessment and innovative drug selection (RAIDs): Paving the way to personalized medicine in cervical cancer

被引：0
|
作者：
de Koning, Leanne
Ouine, Berengere
Cartier, Aurelie
Berns, Els M.
Ruigrok-Ritstier, Kirsten
Beaufort, Corine
Balint, Balazs
Kereszt, Attila
Kenter, Gemma
Samuels, Sanne
Jordanova, Ekaterina S.
Jeannot, Emmanuelle
von der Leyen, Heiko
Popovic, Marina
Luscap-Rondof, Windy
Sibut, Vonick
Kamoun, Choumouss
Britto, Isabel
Rincon, Claudia
Hupe, Philippe
Kamal, Maud
Scholl, Suzy M.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1746
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1746
引用
下载
收藏
页数：2
相关论文
共 11 条
  • [1] Rational molecular assessment and innovative drug selection (RAIDs): exome data from cervical cancer
    Scholl, Suzy
    Kamal, Maud
    Berns, Els
    Balint, Balzs
    Kereszt, Attila
    de Koning, Leanne
    Jeannot, Emmanuelle
    Luscap-Rondof, Windy
    Sibut, Vonick
    Hupe, Philippe
    Kenter, Gemma
    Samuels, Sanne
    Jordanova, Katja
    Blanchet, Sandrine
    Lafanachere, Laurence
    Billaud, Marc
    CANCER RESEARCH, 2016, 76
  • [2] Rational molecular assessment and innovative drug selection (RAIDs): Pharmacological profiling of 20 cervical cancer cell lines
    Kamal, M.
    Bouguern, S.
    Santos, E. Del Nery
    Soria, A.
    Berns, E.
    Kereszt, A.
    Balint, B.
    Kenter, G.
    Samuels, S.
    Jordanova, E.
    De Koning, L.
    Jeannot, E.
    Luscap-Rondof, W.
    Sibut, V.
    Hupe, P.
    Blanchet, S.
    Prudent, R.
    Billaud, M.
    Lafanechere, L.
    Scholl, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S80 - S80
  • [3] RAIDs: Rational Molecular Assessments and Innovative Drug Selection, an EU Funded Project
    Kurzeder, C.
    Scholl, S.
    Kamal, M.
    Banu, E.
    Kenter, G.
    Mustea, A.
    Ngo, C.
    Popovic, M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 176 - 176
  • [4] Targeted nanoparticles in imaging: paving the way for personalized medicine in the battle against cancer
    Shin, Soo J.
    Beech, Jaymes R.
    Kelly, Kimberly A.
    INTEGRATIVE BIOLOGY, 2013, 5 (01) : 29 - 42
  • [5] In-treatment assessment of response in locally advanced NSCLC: Paving the way for personalized medicine
    Usmanij, Edwin A.
    Bussink, Jan
    de Geus-Oei, Lioe-Fee
    LUNG CANCER, 2014, 86 (03) : 374 - 374
  • [6] Paving the road to personalized medicine in cervical cancer: Theranostic biomarker evaluation in a 592-specimen library
    Feldman, R.
    Gatalica, Z.
    Reddy, S. K.
    Tewari, K. S.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 141 - 141
  • [7] Cancer Precision Medicine: From Cancer Screening to Drug Selection and Personalized Immunotherapy
    Deng, Xiaolan
    Nakamura, Yusuke
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2017, 38 (01) : 15 - 24
  • [8] Liquid biopsies and plasma DNA: paving the way for personalized medicine in metastatic castration-resistant prostate cancer
    van Soest, R. J.
    ANNALS OF ONCOLOGY, 2017, 28 (07) : 1408 - 1409
  • [9] Personalized Cancer Medicine: Molecular Diagnostics, Predictive Biomarkers, and Drug Resistance
    de Castro, D. Gonzalez
    Clarke, P. A.
    Al-Lazikani, B.
    Workman, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (03) : 252 - 259
  • [10] Non-small-cell lung cancer: molecular targeted therapy and personalized medicine - drug resistance, mechanisms, and strategies
    Sechler, Marybeth
    Cizmic, Amber D.
    Avasarala, Sreedevi
    Van Scoyk, Michelle
    Brzezinski, Christine
    Kelley, Nicole
    Bikkavilli, Rama Kamesh
    Winn, Robert A.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2013, 6 : 25 - 36
12